Quick Takeaways
- MGRX - MANGOCEUTICALS, INC. has 8 insiders with reported activity on this page.
- Net insider value flow over the last year: -$174,014.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 8 Insiders of MANGOCEUTICALS, INC.
- Symbol
- MGRX on Nasdaq
- Location
- Dallas, TX
What Changed
- Buy value: ; sell value: $174,013.
- Net share flow: -143,333.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$174,014.
Buys
$0
Shares: 0
Insiders: 0
Sells
$174,014
Shares: 143,333
Insiders: 2
Net
-$174,014
Shares: -143,333
Insiders: -2
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 143,333 | $0 | $174,014 | -$174,014 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
MANGOCEUTICALS, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jonathan Arango | President, COO and Secretary, Director | $1,000,000 | Mixed | 20 Mar 2023 | ||
| Jacob D. Cohen | Chief Executive Officer, Director, 10%+ Owner | $260,000 | Mixed | 16 Mar 2026 | ||
| Dr. Kenny Myers | Director | $232,333 | Mixed | 09 Sep 2025 | ||
| Lorraine Pamela D'Alessio | Director | $232,333 | Mixed | 09 Sep 2025 | ||
| Eugene M. Johnston | Cfo | $139,836 | -$21,139 | -13% | Filing P/S | 15 Dec 2025 |
| Amanda Elizabeth Hammer | Chief Operating Officer | $75,000 | Mixed | 03 Jun 2024 | ||
| Alex P. Hamilton | Director | $4,077 | -$152,875 | -97% | Filing P/S | 19 Nov 2025 |
| Antonios Isaac | President, Director | $0 | Mixed | 10 Apr 2025 |
Top shareholders of MANGOCEUTICALS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Jacob D. Cohen |
13D/G
3/4/5
|
Chief Executive Officer, Director, 10%+ Owner |
15%
|
2,044,356
|
$4,599,801 | +$2,526,052 | 21 Jul 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
11%
|
1,536,000
|
$1,136,640 | — | 31 Dec 2025 | |
| Jonathan Arango |
3/4/5
|
President, COO and Secretary, Director |
—
class O/S missing
|
1,000,000
|
$1,000,000 | — | 20 Mar 2023 | |
| GREENFIELD INVESTMENTS LTD. |
13D/G
|
— |
14%
|
515,000
|
$916,700 | $0 | 13 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
489,532
|
$362,254 | — | 31 Dec 2025 | |
| Dr. Kenny Myers |
3/4/5
|
Director |
0.98%
|
136,667
|
$232,333 | — | 09 Sep 2025 | |
| Lorraine Pamela D'Alessio |
3/4/5
|
Director |
0.98%
|
136,667
|
$232,333 | — | 09 Sep 2025 | |
| Eugene M. Johnston |
3/4/5
|
CFO |
0.86%
|
120,000
|
$139,836 | -$21,139 | 15 Dec 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.99%
|
138,146
|
$102,229 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.77%
|
108,322
|
$80,157 | — | 31 Dec 2025 | |
| Amanda Elizabeth Hammer |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
175,000
|
$75,000 | — | 03 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.34%
|
47,503
|
$35,152 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.33%
|
46,167
|
$34,164 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
38,441
|
$28,446 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.27%
|
37,579
|
$27,808 | — | 31 Dec 2025 | |
| Ackerman Capital Advisors, LLC |
13F
|
Company |
0.25%
|
34,500
|
$25,530 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.24%
|
33,462
|
$25,000 | — | 31 Dec 2025 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0.09%
|
12,000
|
$8,880 | — | 31 Dec 2025 | |
| Csenge Advisory Group |
13F
|
Company |
0.07%
|
10,000
|
$7,400 | — | 31 Dec 2025 | |
| Alex P. Hamilton |
3/4/5
|
Director |
0.02%
|
3,334
|
$4,077 | -$152,875 | 19 Nov 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
2,885
|
$2,134 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,002
|
$741 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
1,000
|
$740 | — | 31 Dec 2025 | |
| Fortitude Family Office, LLC |
13F
|
Company |
0%
|
378
|
$280 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
107
|
$79 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2025 | |
| Antonios Isaac |
3/4/5
|
President, Director |
—
class O/S missing
|
60,000
|
— | — | 10 Apr 2025 |
Recent Insider Transactions by Companies or Individuals for MANGOCEUTICALS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jacob D. Cohen | MGRX | Stock Option (right to buy) | Award | 2,133,333 | 2,000,000 | 16 Mar 2026 | Direct | |||
| Jacob D. Cohen | MGRX | Stock Option (right to buy) | Disposed to Issuer | -100% | -2,133,333 | 0 | 16 Mar 2026 | Direct | ||
| Eugene M. Johnston | MGRX | Common Stock | Sale | -2.7% | $3,884 | $1.17 | -3,333 | 120,000 | 15 Dec 2025 | Direct |
| Eugene M. Johnston | MGRX | Common Stock | Sale | -3.9% | $5,975 | $1.20 | -5,000 | 123,333 | 09 Dec 2025 | Direct |
| Eugene M. Johnston | MGRX | Common Stock | Sale | -7.23% | $11,280 | $1.13 | -10,000 | 128,333 | 05 Dec 2025 | Direct |
| Alex P. Hamilton | MGRX | Common Stock | Sale | -97.4% | $152,875 | $1.22 | -125,000 | 3,334 | 19 Nov 2025 | Direct |
| Jacob D. Cohen | MGRX | Common Stock | Award | 500,000 | 500,000 | 09 Sep 2025 | Direct | |||
| Jacob D. Cohen | MGRX | Stock Option (right to buy) | Award | 2,000,000 | 2,000,000 | 09 Sep 2025 | Direct | |||
| Eugene M. Johnston | MGRX | Common Stock | Award | 260.9% | 100,000 | 138,334 | 09 Sep 2025 | Direct | ||
| Lorraine Pamela D'Alessio | MGRX | Common Stock | Award | 272.7% | 100,000 | 136,667 | 09 Sep 2025 | Direct | ||
| Alex P. Hamilton | MGRX | Common Stock | Award | 375% | 100,000 | 126,667 | 09 Sep 2025 | Direct | ||
| Dr. Kenny Myers | MGRX | Common Stock | Award | 272.7% | 100,000 | 136,667 | 09 Sep 2025 | Direct | ||
| Jacob D. Cohen | MGRX | Warrant to Purchase Common Stock | Award | 50,000 | 50,000 | 21 Jul 2025 | Direct | |||
| Jacob D. Cohen | MGRX | Convertible Promissory Note | Award | 0 | $100,000 | 21 Jul 2025 | Direct | |||
| Jacob D. Cohen | MGRX | Common Stock | Gift | 33.1% | 200,000 | 805,000 | 05 Jun 2025 | Direct | ||
| Jacob D. Cohen | MGRX | Common Stock | Gift | -100% | -200,000 | 0 | 05 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.